Genix Pharmaceuticals Corporation

C$0.01As of Sun 8 Nov 2026, 12:00 UTC
TSXV:GENXHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (9.32%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.47
PE TTM —
TSR TTM (50.00%)
Mkt cap C$0.918M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0151
0.55%
(14.03%)
Hold 7|12|7|1|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
14.21%
13.49%
24.10%
34.75%
Revenue$M
0.056
0.057
0.056
0.056
0.03%
5.49%
3.60%
4.94%
Peers (US$0.650M)
Cap (US$)
PE
0.527M
—
Capital
TTM
5Y
10Y
Leveragex
1.394
0.021
0.016
EBIT/Intx
14.62
0.272
0.269
Own earn%
64.02
11.30
(0.79)
Sh yield%
54.00
22.77
21.29
Owners
Insiders/Inst%
4.76
65.72
Short interest%
4.98
SBC / revenue%
2.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
16–20
$1 testx
—
Incr. ROIC%
10